VitreoSub
VitreoSub
VitreoSub is a patented, in-situ gelling hydrogel intended to replace the vitreous body after retinal surgery. VitreoSub was specifically developed to:
– have the same refractive index and viscoelastic properties as the human vitreous body
– perfect optical clarity
– be 100% biocompatible
– allow the sustained drug release to treat retinal diseases (see posterior segment drug release)
– an ultra-low controllable swelling pressure
VitreoSub is the winner of ...
Currently, VitreoSub is undergoing testing in an in-vivo porcine model and is modified to be a platform for retinal drug delivery.
If you are interested in participating in our studies, please see our open positions →.
